Literature DB >> 32413279

Clinical Impact and Regulation of the circCAMSAP1/ miR-328-5p/E2F1 Axis in Colorectal Cancer.

Ion Cristóbal1, Melani Luque2, Marta Sanz-Alvarez2, Federico Rojo2, Jesús García-Foncillas3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32413279      PMCID： PMC7264437          DOI： 10.1016/j.ymthe.2020.05.003

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  15 in total

1.  SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.

Authors:  Feng Wang; Yan-Lei Ma; Peng Zhang; Tong-Yi Shen; Chen-Zhang Shi; Yong-Zhi Yang; Mary-Pat Moyer; Hui-Zhen Zhang; Hong-Qi Chen; Yong Liang; Huan-Long Qin
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

2.  Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma.

Authors:  Murat Kara; Onder Yumrutas; Onder Ozcan; Ozgur Ilhan Celik; Esra Bozgeyik; Ibrahim Bozgeyik; Sener Tasdemir
Journal:  Gene       Date:  2015-04-27       Impact factor: 3.688

3.  Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo.

Authors:  Shunsuke Noguchi; Junya Iwasaki; Minami Kumazaki; Takashi Mori; Kohji Maruo; Hiroki Sakai; Nami Yamada; Kazuyuki Shimada; Tomoki Naoe; Yukio Kitade; Yukihiro Akao
Journal:  Mol Ther       Date:  2013-04-30       Impact factor: 11.454

4.  miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.

Authors:  Zhe Chen; Huazong Zeng; Yong Guo; Pei Liu; Hui Pan; Anmei Deng; Jian Hu
Journal:  J Exp Clin Cancer Res       Date:  2010-11-22

5.  MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC.

Authors:  Warangkana Lohcharoenkal; Masako Harada; Jakob Lovén; Florian Meisgen; Ning Xu Landén; Lingyun Zhang; Jan Lapins; Kunal Das Mahapatra; Hao Shi; Liisa Nissinen; Veli-Matti Kähäri; Mona Ståhle; Enikö Sonkoly; Dan Grandér; Marie Arsenian-Henriksson; Andor Pivarcsi
Journal:  J Invest Dermatol       Date:  2016-07-22       Impact factor: 8.551

6.  circCAMSAP1 Promotes Tumor Growth in Colorectal Cancer via the miR-328-5p/E2F1 Axis.

Authors:  Chi Zhou; Hua-Shan Liu; Feng-Wei Wang; Tuo Hu; Zhen-Xing Liang; Nan Lan; Xiao-Wen He; Xiao-Bin Zheng; Xiao-Jian Wu; Dan Xie; Xian-Rui Wu; Ping Lan
Journal:  Mol Ther       Date:  2019-12-25       Impact factor: 11.454

7.  Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer.

Authors:  Hui Chen; Zhiying Xu
Journal:  Dis Markers       Date:  2015-11-26       Impact factor: 3.434

8.  Overexpressed circPVT1 in oral squamous cell carcinoma promotes proliferation by serving as a miRNA sponge.

Authors:  Tianpeng He; Xin Li; Dongmei Xie; Lili Tian
Journal:  Mol Med Rep       Date:  2019-08-26       Impact factor: 2.952

9.  Circular RNA PVT1 promotes metastasis via regulating of miR-526b/FOXC2 signals in OS cells.

Authors:  Ming Yan; Hang Gao; Zhenshan Lv; Ying Liu; Song Zhao; Weiquan Gong; Wei Liu
Journal:  J Cell Mol Med       Date:  2020-04-05       Impact factor: 5.310

10.  circPVT1 Facilitates Invasion and Metastasis by Regulating miR-205-5p/c-FLIP Axis in Osteosarcoma.

Authors:  Yu-Peng Liu; Jun Wan; Feng Long; Jian Tian; Can Zhang
Journal:  Cancer Manag Res       Date:  2020-02-18       Impact factor: 3.989
View more
  2 in total

1.  CircCAMSAP1 promotes hepatocellular carcinoma progression through miR-1294/GRAMD1A pathway.

Authors:  Zongjiang Luo; Libai Lu; Qianli Tang; Wang Wei; Pengyu Chen; Yichen Chen; Jian Pu; Jianchu Wang
Journal:  J Cell Mol Med       Date:  2021-01-23       Impact factor: 5.310

2.  MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer.

Authors:  Cheng-You Jia; Wei Xiang; Ji-Bin Liu; Geng-Xi Jiang; Feng Sun; Jian-Jun Wu; Xiao-Li Yang; Rui Xin; Yi Shi; Dan-Dan Zhang; Wen Li; Zavuga Zuberi; Jie Zhang; Gai-Xia Lu; Hui-Min Wang; Pei-Yao Wang; Fei Yu; Zhong-Wei Lv; Yu-Shui Ma; Da Fu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.